Total Payments
$50,478
2024 Payments
$20,373
Companies
23
Transactions
145
Medicare Patients
6,863
Medicare Billing
$585,547
Payment Breakdown by Category
Other$32,646 (64.7%)
Travel$11,297 (22.4%)
Food & Beverage$5,035 (10.0%)
Consulting$1,500 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,646 | 10 | 64.7% |
| Travel and Lodging | $11,297 | 8 | 22.4% |
| Food and Beverage | $5,035 | 122 | 10.0% |
| Consulting Fee | $1,500 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $46,826 | 54 | $0 (2024) |
| Abbott Laboratories | $1,933 | 33 | $0 (2024) |
| Celgene Corporation | $300.00 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $271.11 | 15 | $0 (2023) |
| ABIOMED | $169.72 | 3 | $0 (2024) |
| PFIZER INC. | $163.56 | 5 | $0 (2024) |
| CVRx, Inc. | $125.80 | 3 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $114.93 | 5 | $0 (2024) |
| Amgen Inc. | $84.08 | 5 | $0 (2023) |
| Novo Nordisk Inc | $68.41 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,373 | 49 | E.R. Squibb & Sons, L.L.C. ($19,553) |
| 2023 | $24,252 | 42 | E.R. Squibb & Sons, L.L.C. ($23,474) |
| 2022 | $4,898 | 24 | E.R. Squibb & Sons, L.L.C. ($3,798) |
| 2021 | $848.37 | 24 | Abbott Laboratories ($436.78) |
| 2020 | $67.35 | 4 | Novartis Pharmaceuticals Corporation ($48.69) |
| 2018 | $25.38 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25.38) |
| 2017 | $14.66 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($14.66) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Heart Failure | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Travel and Lodging | Cash or cash equivalent | $3,169.57 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Travel and Lodging | Cash or cash equivalent | $2,159.19 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $125.01 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Travel and Lodging | Cash or cash equivalent | $101.16 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $36.94 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $121.35 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,604.00 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Heart Failure | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $125.06 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $55.23 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $137.05 | General |
| Category: Heart Failure | ||||||
| 10/17/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Heart Failure | ||||||
| 10/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Heart Failure | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.30 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Heart Failure | ||||||
| 09/15/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Heart Failure | ||||||
| 08/30/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $133.92 | General |
| Category: Heart Failure | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.24 | General |
| Category: Cardiovascular | ||||||
| 08/08/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $39.67 | General |
| Category: Vascular | ||||||
| 08/08/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,192 | 2,805 | $605,457 | $201,577 |
| 2022 | 32 | 2,071 | 2,557 | $503,439 | $167,003 |
| 2021 | 31 | 1,810 | 2,209 | $440,768 | $152,438 |
| 2020 | 21 | 790 | 908 | $274,549 | $64,528 |
Total Patients
6,863
Total Services
8,479
Medicare Billing
$585,547
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 280 | 535 | $148,730 | $68,826 | 46.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 103 | 306 | $61,812 | $28,582 | 46.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 242 | 248 | $50,840 | $12,901 | 25.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 119 | 124 | $41,416 | $10,334 | 25.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 77 | $30,261 | $10,132 | 33.5% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 116 | 116 | $40,600 | $9,950 | 24.5% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 124 | 125 | $36,500 | $8,001 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 53 | 53 | $21,094 | $7,896 | 37.4% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 77 | 77 | $30,800 | $7,391 | 24.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 16 | 40 | $21,360 | $6,382 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 47 | $9,754 | $4,111 | 42.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 41 | 48 | $18,720 | $4,078 | 21.8% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 21 | 21 | $14,679 | $3,666 | 25.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 244 | 282 | $16,920 | $3,004 | 17.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 35 | 35 | $11,103 | $2,671 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,400 | $2,309 | 36.1% |
| 75635 | Ct scan of abdominal aorta and both leg arteries with contrast | Facility | 2023 | 22 | 22 | $8,052 | $1,912 | 23.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 24 | $3,384 | $1,493 | 44.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,752 | $1,430 | 38.1% |
| 74174 | Ct scan of blood vessels of abdomen and pelvis with contrast | Facility | 2023 | 14 | 14 | $4,452 | $1,107 | 24.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 48 | 48 | $3,360 | $769.68 | 22.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 14 | 14 | $3,892 | $727.84 | 18.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 31 | 36 | $2,988 | $701.06 | 23.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 115 | 123 | $2,952 | $680.63 | 23.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 35 | 36 | $2,844 | $547.25 | 19.2% |
About Jonathan Ginns, MBBS MD
Jonathan Ginns, MBBS MD is a Cardiovascular Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962737692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jonathan Ginns, MBBS MD has received a total of $50,478 in payments from pharmaceutical and medical device companies, with $20,373 received in 2024. These payments were reported across 145 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,646).
As a Medicare-enrolled provider, Ginns has provided services to 6,863 Medicare beneficiaries, totaling 8,479 services with total Medicare billing of $585,547. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Adult Congenital Heart Disease
- Location Austin, TX
- Active Since 10/14/2009
- Last Updated 01/12/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1962737692
Products in Payments
- CAMZYOS (Drug) $45,895
- CARDIOMEMS (Device) $687.30
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $469.90
- ENTRESTO (Drug) $242.39
- MITRACLIP (Device) $183.92
- Impella (Device) $169.72
- Confirm Rx (Device) $152.91
- MitraClip System (Device) $143.47
- HeartMate 3 Left Ventricular Assist Device (Device) $140.40
- VYNDAQEL (Drug) $135.03
- Barostim Neo System (Device) $125.80
- ONPATTRO (Drug) $114.93
- Repatha (Biological) $84.08
- Ozempic (Drug) $68.41
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $64.91
- AMPLATZER AMULET (Device) $63.48
- ELIQUIS (Drug) $59.42
- OPTIMIZER (Device) $55.30
- EPIC (Device) $50.12
- FFRct (Device) $46.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Austin
Dr. Andrea Natale, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M
Dr. Jason Zagrodzky, M.d, M.D
Cardiovascular Disease — Payments: $953,600
Cardiovascular Disease $953,600
Dr. Rodney Horton, M.d, M.D
Cardiovascular Disease — Payments: $720,616
Cardiovascular Disease $720,616
Francis Zidar, Md, MD
Cardiovascular Disease — Payments: $448,847
Cardiovascular Disease $448,847
Vivek Goswami, Md, MD
Cardiovascular Disease — Payments: $338,027
Cardiovascular Disease $338,027
Dr. Robert Canby, M.d, M.D
Cardiovascular Disease — Payments: $225,010
Cardiovascular Disease $225,010